Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.
For Advaxis, Bacteria Help More Than They Hurt
The idea of using harmful bacteria to treat disease might strike many as an odd concept.
CytRx Puts Its Cancer Pipeline to the Test
All told, the Los Angeles-based company could have six to eight trials running simultaneously in the coming months.
Quintessence Biosciences’ Novel Approach to Cancer Therapy
Quintessence Biosciences is a biopharmaceutical company specializing in the development of novel protein-based therapeutics to fight cancer.
The Universal Vaccines of Inovio Biomedical
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
TapImmune Taps Into Cancer Defense
How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?
[OneMedForum] Clarient Grows Along with Cancer Testing Market
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
[OneMedForum] Alexza Pharmaceuticals’ Pipeline Is Built for Speed
Alexza Pharmaceuticals of Mountain View, Calif., is focused on the development of inhalation drugs for the treatment of central nervous system disorders.
